Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens.

Literature DB >> 15872290

Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens.

Diane M Citron¹, Yumi A Warren, Helen T Fernandez, Maurice A Goldstein, Kerin L Tyrrell, Ellie J C Goldstein.

Abstract

Broth microdilution and disk diffusion susceptibility testing were performed on 73 strains of Pasteurella species isolated from human infections and on five American Type Culture Collection strains of Pasteurella species. Both methods appear reliable for testing susceptibilities of Pasteurella species.

Entities: Disease Species

Mesh：

Substances：
Anti-Bacterial Agents

Year: 2005 PMID： 15872290 PMCID： PMC1153779 DOI： 10.1128/JCM.43.5.2485-2488.2005

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

14 in total

Review 1. Lung abscess due to beta-lactamase-producing Pasteurella multocida.

Authors: C Lion; A Lozniewski; V Rosner; M Weber
Journal: Clin Infect Dis Date: 1999-11 Impact factor: 9.079

Review 2. Need for susceptibility testing guidelines for fastidious or less-frequently isolated bacteria.

Authors: James H Jorgensen
Journal: J Clin Microbiol Date: 2004-02 Impact factor: 5.948

3. New plasmid-borne antibiotic resistance gene cluster in Pasteurella multocida.

Authors: Corinna Kehrenberg; Nga Thi Thu Tham; Stefan Schwarz
Journal: Antimicrob Agents Chemother Date: 2003-09 Impact factor: 5.191

4. Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida.

Authors: E J Goldstein; D M Citron; G A Richwald
Journal: Antimicrob Agents Chemother Date: 1988-02 Impact factor: 5.191

5. In vitro activity of oral antimicrobial agents against clinical isolates of Pasteurella multocida.

Authors: J E Mortensen; O Giger; G L Rodgers
Journal: Diagn Microbiol Infect Dis Date: 1998-02 Impact factor: 2.803

6. Erythromycin failure with subsequent Pasteurella multocida meningitis and septic arthritis in a cat-bite victim.

Authors: J M Levin; D A Talan
Journal: Ann Emerg Med Date: 1990-12 Impact factor: 5.721

7. Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections.

Authors: E J Goldstein; D M Citron; C V Merriam; Y Warren; K Tyrrell
Journal: Antimicrob Agents Chemother Date: 2000-09 Impact factor: 5.191

Review 3. Pet-related Pasteurella multocida induced peritonitis in peritoneal dialysis: a case report and review of the literatures.

Authors: Haoran Mu; Man Yang; Yueyue Zhang; Yajing Zhang; Juan Wang; Weijie Yuan; Shu Rong
Journal: BMC Nephrol Date: 2020-03-19 Impact factor: 2.388

3 in total

Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens.

Review 1. Lung abscess due to beta-lactamase-producing Pasteurella multocida.

Review 2. Need for susceptibility testing guidelines for fastidious or less-frequently isolated bacteria.

3. New plasmid-borne antibiotic resistance gene cluster in Pasteurella multocida.

4. Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida.

5. In vitro activity of oral antimicrobial agents against clinical isolates of Pasteurella multocida.

6. Erythromycin failure with subsequent Pasteurella multocida meningitis and septic arthritis in a cat-bite victim.

7. Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections.

8. Bacteriology of human and animal bite wounds.

9. Molecular characterization of plasmids with antimicrobial resistant genes in avian isolates of Pasteurella multocida.

10. In vitro activities of garenoxacin (BMS-284756) against 170 clinical isolates of nine Pasteurella species.

1. The first case of Pasteurella canis bacteremia: a cirrhotic patient with an open leg wound.

2. Identification of Pasteurella canis in a Soft Tissue Infection Caused by a Dog Bite: The First Report in Korea.

Review 3. Pet-related Pasteurella multocida induced peritonitis in peritoneal dialysis: a case report and review of the literatures.